Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
2014
Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA
School's IN for summer: HAI staff and interns inspired by Utrecht University's course on pharmaceutical policy analysis
Setting precedents: EMA must get clinical trial data policy right to truly act in public interest
HAI Europe calls on EMA's Management Board to stand for data transparency
Tamiflu review shows desperate need for full clinical trials data transparency
A new (and improved) model to regulate pharmaceutical promotion
Enhancing accountability in the medicines market: The Medicines Transparency Alliance
Bayer CEO's callous comments highlight failure of current biomedical innovation model
2013
When politicians go to the movies
2011
DG Trade State of Play reveals EU's ambitions for IP protection in FTAs
European drug regulator challenged over revolving door case involving former Director
Corporate funding linked to EU patient & consumer groups policy
2010